Berkeley Lights News Today

ABCL earnings call for the period ending September 30, 2023.

The global Cell Line Development market is anticipated to grow at a CAGR of 9.6% during the forecast period (2023-2030).

BioPharma

Amongst a challenging funding landscape, PhenomeX emerges by clinching an irresistible deal With Bruker. Here's more on the transaction.

PhenomeX Inc. stock has more than doubled on Thursday after Bruker Corp. said it would acquire the Emeryville, Calif.-based, cell biology company for $1 a...

Acquisition initiates Bruker’s entry into functional single-cell biology research solutions ...

Bruker Corporation (NASDAQ: BRKR) has agreed to acquire PhenomeX Inc (NASDAQ: CELL) for $1.00 per share in an 

Acquisition initiates Bruker’s entry into functional single-cell biology research solutionsBILLERICA, Mass. & EMERYVILLE, Calif.--(BUSINESS WIRE)--#BRKR--Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for...

Strategic Alternatives Process Continuing; Board Focused on Maximizing Stockholder Value EMERYVILLE, Calif., Aug. 14, 2023 /PRNewswire/ -- PhenomeX, Inc. , a life sciences tools company, today... -Today at 04:06 pm- MarketScreener

/PRNewswire/ -- PhenomeX, Inc. (Nasdaq: CELL), a life sciences tools company, today reported financial results for the second quarter ended June 30, 2023....